WEDNESDAY, Oct. 3, 2018 -- Many older breast cancer patients might worry that they will be struck by "chemo brain" after their treatments, but a new study suggests that only those who carry a gene linked to Alzheimer's face that risk.
Researchers found that breast cancer survivors carrying the APOE4 gene who underwent chemotherapy were more likely to experience long-term impairment in brain function.
THURSDAY, Sept. 20, 2018 -- By 2060, almost 14 million Americans will suffer from Alzheimer's disease, a number that's nearly three times as high as today, a new report projects.
"This study shows that as the U.S. population increases, the number of people affected by Alzheimer's disease and related dementias will rise, especially among minority populations," said Dr. Robert Redfield, director of the U.S. Centers for Disease Control and Prevention.
TUESDAY, Sept. 25, 2018 -- Regular exercise might delay a rare form of early onset Alzheimer's disease, a new study suggests.
Researchers found that 2.5 hours of walking or other physical activity a week thwarted mental decline tied to autosomal dominant Alzheimer's disease (ADAD). This is an inherited form of disease that leads to dementia at an early age.
TUESDAY, Sept. 11, 2018 -- Feeling drowsy during the day might mean you have an increased risk for Alzheimer's, new research suggests.
The long-term study included 123 adults with an average age of 60 when the study began. The findings showed that those who were very sleepy during the day had a nearly threefold increased risk of developing brain deposits of beta-amyloid, a protein associated with Alzheimer's disease.
THURSDAY, Aug. 23, 2018 -- An eye exam might spot people with Alzheimer's disease before they show any symptoms, researchers report.
"All of us have a small area devoid of blood vessels in the center of our retinas that is responsible for our most precise vision. We found that this zone lacking blood vessels was significantly enlarged in people with pre-clinical Alzheimer's disease," explained co-principal investigator Dr. Rajendra Apte. He is a professor of ophthalmology and visual sciences at Washington University School of Medicine in St. Louis.